innoscripta Aktie
110,60EUR | -0,60EUR | -0,54% |
WKN DE: A40QVM / ISIN: DE000A40QVM8
Personal
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Personal am Ende des Jahres | 0 | 0 | 0 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Summe Umlaufvermögen | 17 | 29 | 35 | 58 |
Summe Anlagevermögen | 0 | 1 | 1 | 1 |
Summe Aktiva | 17 | 30 | 35 | 59 |
Bilanz (in Mio. EUR) - Passiva
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Summe Fremdkapital | 7 | 17 | 17 | 24 |
Summe Eigenkapital | 11 | 13 | 18 | 35 |
Summe Passiva | 17 | 30 | 35 | 59 |
Adresse
Arnulfstrasse 60, 80335 Munich | |
Telefon | +49 (89) 25555-3537 |
Internet | http://www.innoscripta.com |
Management
Alexander Meyer
Chief Financial Officer |
Christoph Möller
Deputy Chairman-Supervisory Board |
Erik Massmann
Member-Supervisory Board |
Kai Andrejewski
Member-Supervisory Board |
Michael Georg Hohenester
Chief Executive Officer |
Philipp von Ilberg
Chairman-Supervisory Board |
Sebastian Schwertlein
Chief Operating Officer |
Stefan Berndt-von Bülow
Member-Supervisory Board |